Sinopharm puts three antibody COVID treatments into trial
Zhu Jingjin, deputy president of China National Biotec Group, China National Pharmaceutical Group's biotech subsidiary, said at a media conference in Beijing on Monday the company's three virus neutra
Comment here to discuss with all recipients or tap a user's profile image to discuss privately.